This compound is the hemifumarate salt of aliskiren, a pharmaceutical intermediate used in research and manufacturing processes. It is a multi-component, salt-like substance with complex stereochemistry and a large, flexible molecular structure.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1630036-76-8
(3S,4R)-4-aminooxan-3-ol hydrochloride
pharmaceutical intermediate
(3R,4S)-3-Fluorotetrahydro-2H-pyran-4-amine hydrochloride
Pharmaceutical intermediate
Tert-butyl N-[(3R,4S)-3-fluoropiperidin-4-yl]carbamate
Pharmaceutical intermediate for drug synthesis
(2R,3R,4R,5R)-2-(Acetoxymethyl)-5-(2-amino-6-chloro-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
protected riboside intermediate for nucleoside synthesis
(2S,4S,5S,7R)-5-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide;(E)-but-2-enedioic acid
n.a
Aliskiren
active pharmaceutical ingredient
Aliskiren hemifumarate
active pharmaceutical ingredient
Aliskiren hydrochloride
active pharmaceutical ingredient
bis((2R,4R,5R,7R)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
KLRSDBSKUSSCGU-CTOTZSFUSA-N
CC(C)[C@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@H]([C@@H](C[C@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)[C@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@H]([C@@H](C[C@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=C/C(=O)O)\C(=O)O